How much funding has Network Bio raised?

Network Bio has raised $19.5M in total funding, most recently a Seed round.

Who are Network Bio's investors?

Network Bio's investors include Section 32, Breyer Capital.

When was Network Bio founded?

Network Bio was founded in 2022.

Where is Network Bio headquartered?

Network Bio is headquartered in New York, New York, United States.

What industry is Network Bio in?

Network Bio operates in Artificial Intelligence, Data & Analytics, Genomics, Healthcare.

How many employees does Network Bio have?

Network Bio has 11-50 employees.

Network Bio

Securitizing biomedical data for precision medicine

New York, United States · Founded 2022 · $19.5M raised

Artificial Intelligence

Data & Analytics

Genomics

Healthcare

Headquarters: New York, New York
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: network.bio
Total Funding: $19.5M
Last Round: $2.5M SeedFeb 2025
Rounds: 2

About

Network Bio creates research-grade biomedical data assets in partnership with healthcare institutions, serving as a neutral broker between institutions and life-science industry partners for precision medicine advancement. The platform delivers multi-modal, diverse datasets supporting researchers in academia and industry who are tackling common human diseases. The team draws on expertise in computational biology, population genomics, multi-omic algorithms, and biobanking technology, having previously worked at organizations partnered with the Mayo Clinic, Duke, and other leading US institutions.

Summary

Network Bio is an Artificial Intelligence company based in New York, United States, founded in 2022. It has raised $19.5M in total across 2 rounds, most recently a $2.5M Seed round in Feb 2025. Investors include Section 32 and Breyer Capital.